Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • fgajardoe
    Junior Member
    • Apr 2013
    • 7

    Sweet spot coverage. why?

    Hi everybody!

    I'm a little confused with the "why" of the existence of a "sweet spot" coverage when assembling a genome.

    for example, i have been reading that the sweet spot to 454 dataset is between 60X ~ 80X, and more coverage could result in missassemblies. I thought that as more coverage, lesser error probability in each base.

    I imagine there is some kind of distribution related to the error rate of the sequencing technology used. but i'm not clear.

    thanks in advance!
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    There are a number of factors at play here, but it is unsurprising to be confused as most statistical problems do better with more data; assembly is unusual in falling apart.

    One issue is with implementation. Every sequencing error creates a spray of new possibilities for the assembler; with many errors, the computational resources to sort these out grows with a worse than linear trend.

    Many sequencing errors are not fully random either, so with more coverage the data is more likely to have repetitions of the same systematic error. Greater coverage is also more likely to generate very rare but very troublesome errors, such as chimaeric library members.

    Also factoring into this is that at some point more data cannot actually help; the capability of a given technology on that genome will have been exhausted.

    I think your guess about error rate is on track, though the class of error probably matters also (insertion/deletion vs. substitution). Error correcting stages upstream of assembly may also benefit from higher coverage that would cause problems for straight assembly.

    Comment

    • fgajardoe
      Junior Member
      • Apr 2013
      • 7

      #3
      thanks! it is more clear now!
      so, if i have a 454 dataset with 300X coverage. and i subsampled it until 80X and then assemble. is a bad idea to use the (or part of the) excluded reads to extend contigs?

      or would be better run several assemblies with 80X coverage datasets, but taking different randomly choosen reads and select the best assembly? (it could be a little time-consuming, i know )

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      210 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      78 views
      0 reactions
      Last Post SEQadmin2  
      Working...